 "Coronavirus, vaccine, covid, drugs, clinical trials")
Hyderabad-based Hetero will work with the Russian Direct Investment Fund (RDIF) to produce 100 million doses of Covid-19 vaccine Sputnik V per year for India. The parties plan to start the production of Sputnik V in the beginning of 2021, a statement said.
Earlier this week, RDIF Chief Executive Officer Kirill Dimitriev had announced the Russia sovereign wealth fund’s plan to supply 1 billion doses of Sputnik V across the globe in 2021. RDIF claimed more than 50 countries had requested for over 1.2 billion doses of Sputnik V vaccine. It has forged partnerships in India, China, Brazil, Korea, Hungary,
